Safety and pharmacokinetics of multiple dose myo-inositol in preterm infants. - Wikidata - wikimedia - TriplyDB

Safety and pharmacokinetics of multiple dose myo-inositol in preterm infants.

Safety and pharmacokinetics of multiple dose myo-inositol in preterm infants.

http://www.wikidata.org/entity/Q37544118

about

Role of cytokines and treatment algorithms in retinopathy of prematurity.Opportunities in posthemorrhagic hydrocephalus research: outcomes of the Hydrocephalus Association Posthemorrhagic Hydrocephalus Workshop.

P2860

Q36264828-5A1CA5A4-5606-44D8-81C1-E21BC3829C75 Q55069307-F1C56BA3-2E8E-4723-B511-C5AEA40E2FAA

P2860

Safety and pharmacokinetics of multiple dose myo-inositol in preterm infants.

http://www.wikidata.org/entity/Q37544118

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 13 April 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Safety and pharmacokinetics of multiple dose myo-inositol in preterm infants.

@en

Safety and pharmacokinetics of multiple dose myo-inositol in preterm infants.

@nl

type

label

Safety and pharmacokinetics of multiple dose myo-inositol in preterm infants.

@en

Safety and pharmacokinetics of multiple dose myo-inositol in preterm infants.

@nl

prefLabel

Safety and pharmacokinetics of multiple dose myo-inositol in preterm infants.

@en

Safety and pharmacokinetics of multiple dose myo-inositol in preterm infants.

@nl

P1433

Q37544118-6C861D55-67D5-4F19-9671-1D8FD5B1EBB1

P1476

Q37544118-0D4762D0-2D97-4316-94C8-F353696E064E

P2093

Q37544118-07E99C5B-2FA2-46D6-A685-F068D55D0957

Q37544118-0D52B8C0-E787-4A64-83D2-EFBA905DEDE5

Q37544118-17E7A62B-73FE-4DB1-BD88-8DB46DCD208B

Q37544118-22A888AA-1C52-488E-932B-20151B747A37

Q37544118-27E61FB2-F687-4100-AF51-839EEBB08B82

Q37544118-2806BE25-4825-4482-8331-BF052ED5CC4E

Q37544118-2AC71686-026B-478E-9BEF-DD80C4E6DF3D

Q37544118-34D6764A-B50F-4C1A-A77B-6A45E8FA554F

Q37544118-35D93956-B2AB-44F9-8CE8-DE92266E563B

Q37544118-4346D434-AE44-45C7-842D-BB79D38F9303

P2860

Q37544118-19EB6A75-5630-49D4-83BD-DE79E3F825FB

Q37544118-37D73B25-71E9-4669-B9F7-EDB3A6D75438

Q37544118-3A305DE4-EE3F-450A-8C97-25D971ED4C78

Q37544118-3A7518EC-EB96-470D-9FDC-294A03A638DD

Q37544118-41C92B41-D978-44B6-9F2A-70C04EAF56B4

Q37544118-45A9813E-BB77-44A2-AA4B-519023B909ED

Q37544118-4C6483C5-9A48-4597-B1A8-98AD05C7DBE0

Q37544118-67E3788E-1ABE-43E6-9599-070217184C01

Q37544118-7D017ABF-80CC-42C8-9A02-DEDE37C1E033

Q37544118-99C06B92-F8CB-4816-81C0-2FD634A7741D

P2888

Q37544118-1B352259-185F-43F7-9BDC-D551928158C9

P304

Q37544118-D7692E69-4C5E-4AA2-99A0-183CA20C145E

P31

Q37544118-5472867F-0EEF-42C4-AB42-CC517E87E747

P356

Q37544118-25C75271-0A56-4FF4-B116-F9871D81C54D

P407

Q37544118-BEB5EB6D-9929-4A2D-B8B4-C5DE5A50F7C2

P433

Q37544118-B15930BD-91FA-4DCF-B4AA-0FBF84506CD5

P478

Q37544118-C7124DBC-F614-4B4E-AE17-440234465D8F

P50

Q37544118-2AABBAAA-17E6-4AB5-AE26-B0DE9E156184

Q37544118-646CADC7-492A-4695-A6EE-F17E227DD400

Q37544118-D99B7D2D-2F21-4B96-AAD8-968351048E6A

Q37544118-F7AAC92C-9382-456F-9714-AD4D7830A367

P577

Q37544118-D1F798B8-2341-477F-8D87-2A579033EB4A

P6179

Q37544118-802DD285-A739-44BF-9864-411D4AB23B46

P698

Q37544118-8DA0D22F-A907-4582-A0CD-776A19BC2E0B

P921

Q37544118-22E299A1-E1F9-4709-BD5D-735BFF0A3E6E

P932

Q37544118-ADC2F4DD-AF5F-4E1A-9730-5EE89B91B09A

P356

P1433

Pediatric Research

P1476

Safety and pharmacokinetics of multiple dose myo-inositol in preterm infants.

@en

P2093

Brenda B Poindexter

http://www.w3.org/2001/XMLSchema#string

C Michael Cotten

http://www.w3.org/2001/XMLSchema#string

Conra Backstrom Lacy

http://www.w3.org/2001/XMLSchema#string

David P Carlton

http://www.w3.org/2001/XMLSchema#string

Ivan D Frantz

http://www.w3.org/2001/XMLSchema#string

Kristi L Watterberg

http://www.w3.org/2001/XMLSchema#string

Kristin M Zaterka-Baxter

http://www.w3.org/2001/XMLSchema#string

M Bethany Ball

http://www.w3.org/2001/XMLSchema#string

Michael Goedecke

http://www.w3.org/2001/XMLSchema#string

Michele C Walsh

http://www.w3.org/2001/XMLSchema#string

P2860

Inositol in preterm infants at risk for or having respiratory distress syndrome

Characterization of vascular endothelial growth factor's effect on the activation of protein kinase C, its isoforms, and endothelial cell growth

Evidence-based screening criteria for retinopathy of prematurity: natural history data from the CRYO-ROP and LIGHT-ROP studies.

Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial.

Screening examination of premature infants for retinopathy of prematurity.

Population pharmacokinetics. A regulatory perspective.

Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network

The International Classification of Retinopathy of Prematurity revisited.

Quantification of myo-inositol, 1,5-anhydro- D-sorbitol, and D-chiro-inositol using high-performance liquid chromatography with electrochemical detection in very small volume clinical samples

Age terminology during the perinatal period.

P2888

P304

209-217

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/PR.2016.97

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

80

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-04-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1012338891

http://www.w3.org/2001/XMLSchema#string

P698

27074126

http://www.w3.org/2001/XMLSchema#string

P921

P932

5198845

http://www.w3.org/2001/XMLSchema#string